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Candida albicans expresses specific virulence traits that promote disease establishment and progression.
These traits include morphological transitions between yeast and hyphal growth forms that are thought to
contribute to dissemination and invasion and cell surface adhesins that promote attachment to the host. Here,
we describe the regulation of the adhesin gene ALS3, which is expressed specifically during hyphal development
in C. albicans. Using a combination of reporter constructs and regulatory mutants, we show that this regulation
is mediated by multiple factors at the transcriptional level. The analysis of ALS3 promoter deletions revealed
that this promoter contains two activation regions: one is essential for activation during hyphal development,
while the second increases the amplitude of this activation. Further deletion analyses using the Renilla
reniformis luciferase reporter delineate the essential activation region between positions 471 and 321 of the
promoter. Further 5 or 3 deletions block activation. ALS3 transcription is repressed mainly by Nrg1 and
Tup1, but Rfg1 contributes to this repression. Efg1, Tec1, and Bcr1 are essential for the transcriptional
activation of ALS3, with Tec1 mediating its effects indirectly through Bcr1 rather than through the putative
Tec1 sites in the ALS3 promoter. ALS3 transcription is not affected by Cph2, but Cph1 contributes to full ALS3
activation. The data suggest that multiple morphogenetic signaling pathways operate through the promoter of
this adhesin gene to mediate its developmental regulation in this major fungal pathogen.
Candida albicans is a major opportunistic pathogen of hu-
mans (54). This fungus is a frequent cause of superficial oral
and vaginal infections, and in immunocompromised patients,
C. albicans can disseminate via the bloodstream to invade
internal organs, thereby causing deep-seated, systemic infec-
tions that are often fatal (54).
Various factors are thought to contribute to the virulence of
C. albicans. These include adhesion to host tissue, the ability to
undergo reversible morphogenetic transitions between bud-
ding (yeast) and filamentous (hyphae and pseudohyphae)
growth forms, the secretion of extracellular hydrolases, and
rapid switching between different phenotypic forms (30, 42, 44,
65). The contribution of yeast-hypha morphogenesis to C. al-
bicans virulence has been hotly debated (21, 29, 71). However,
it is clear that hyphal development is closely associated with
tissue invasion (21, 61, 71, 83).
Adherence plays a key role in fungal colonization (27, 68,
70). C. albicans expresses an array of adhesin genes including
HWP1, which encodes a cell surface glycoprotein that acts as a
target for mammalian transglutaminases. These enzymes are
thought to generate covalent cross-links between Hwp1 on the
fungal hyphal surface and proteins on the mammalian cell
surface (68, 72). The ALS gene gamily encodes a set of differ-
entially regulated cell surface glycosylphosphatidylinositol-an-
chored glycoproteins that promote fungal adherence (27, 55).
ALS3 was initially identified as a member of this gene family
that is expressed specifically during hyphal development (28).
A second hypha-specific ALS gene (ALS8) (40) was later iden-
tified as an allele of the ALS3 gene (81). C. albicans als3/als3
cells are defective in biofilm formation (53, 82). Furthermore,
Als3 is involved in adhesion to endothelial and epithelial cells
(55), and als3/als3 cells display an almost total lack of epithelial
destruction in a reconstituted buccal human epithelium model
(81). ALS3 expression has been detected in clinical vaginal
fluid specimens and in a vaginal candidiasis model (13). These
observations indicate a role for ALS3 in the pathogenicity of C.
albicans.
A complex network of signaling pathways regulates yeast-
hypha morphogenesis (10). Following exposure to serum, hy-
phal development is activated by a cyclic AMP-protein kinase
A pathway that regulates the activity of the -helix-loop-helix
transcription factor Efg1 (42, 69). In addition, a mitogen-acti-
vated protein kinase pathway, which includes the Ste12-like
transcription factor Cph1, activates hyphal development under
starvation conditions (38, 41). Additional regulatory factors
contribute to the activation of hyphal development, but their
relationship to these main signaling pathways remains to be
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established (11, 16, 39, 57). These include the transcription
factors Tec1 and Cph2, the inactivation of which causes defects
in hyphal development (37, 62). Tec1 is a TEA (TEF-1, Tec1p,
and AbaAp)/ATTS (AbaAp, TEF-1, Tec1p, and Scalloped)
motif transcription factor that is also required for C. albicans
virulence (62). It was previously suggested that TEC1 is regu-
lated both by Cph2 and Efg1 (36), but their precise roles in
gene regulation during hyphal development are not known.
Hyphal development is negatively regulated by the transcrip-
tional repressors Tup1, Nrg1, and Rfg1 (6, 9, 31, 46). In the
absence of hypha-inducing signals, the global repressor Tup1
inhibits the transcription of hypha-specific genes. This repres-
sion is dependent upon Nrg1, which binds to Nrg1 response
elements (NREs) in the promoters of these genes and targets
Tup1 to these promoters (9, 18, 46). Current models suggest
that Rfg1 is a second DNA-binding protein that targets Tup1
to the promoters of hypha-specific genes, although Nrg1 ap-
pears to make the major contribution to the repression of
hyphal development (31, 32).
The prevailing view is that these morphogenetic signaling
pathways combine to regulate the transcription of hypha-spe-
cific genes. Genome-wide and gene-specific studies have re-
vealed only a small number of hypha-specific genes in C. albi-
cans. These include ALS3, ECE1, HGC1, HWP1, HYR1, RBT1,
and RBT4 (2, 5, 8, 28, 48, 67, 83). As described above, ALS3
and HWP1 encode adhesins. The inactivation of RBT1 or
RBT4 attenuates C. albicans virulence (9). HGC1 encodes a
hypha-specific cyclin required for hyphal development and vir-
ulence (83). With the exception of HGC1, all known hypha-
specific genes appear to encode secreted or cell wall proteins.
These observations reinforce the tight link between the forma-
tion of hyphae, the cell surface, and C. albicans virulence.
In this paper, we have examined the organization of the
ALS3 promoter and determined the relative contributions of
key morphogenetic transcription factors to the regulation of
this hypha-specific gene. We find that, relative to other C.
albicans genes, the promoter regions of ALS3 and other hypha-
specific genes are unusually large. We show that the ALS3
promoter is complex, requiring a 150-bp region for hypha-
specific activation. This promoter integrates inputs from mul-
tiple activators and repressors. Related observations have been
made for a second hypha-specific gene (HWP1) by Kim et al. in
the accompanying paper (33).
MATERIALS AND METHODS
Strains and growth conditions. C. albicans strains (Table 1) were grown in
YPD at 30°C (63). Hyphal development was induced using 20% bovine calf
serum (73).
Strain construction. To generate the C. albicans strains carrying in situ ALS3-
GFP promoter fusions, yeast enhanced green fluorescent protein (GFP) was first
integrated immediately downstream of the start codon at the ALS3 locus to
create SAC500 (Table 1) (14). This was done by PCR amplifying a GFP-URA3
cassette (19) (primers ALS3-F1 and ALS3-F2) (see Table S1 in the supplemental
material) and transforming it into C. albicans RM1000 (77). The correct inte-
gration at the ALS3 locus in Ura-positive or -negative transformants was con-
firmed by whole-cell PCR (60) and Southern blotting (not shown). Promoter
deletions were created at the ALS3-GFP allele by PCR amplifying HIS1 (15) with
primers designed to target this marker to specific regions of the ALS3 upstream
region (see Table S1 in the supplemental material). The correct integration of
HIS1 upstream of the ALS3-GFP allele in His-positive or -negative and Ura-
positive or -negative transformants was confirmed by PCR and Southern blot-
ting. C. albicans strains with mutated Tec1 sites in the ALS3 promoter were made
in the same way by using 5 PCR primers that contain mutations in these
sequences (see Table S1 in the supplemental material). These mutations in the
C. albicans genome were confirmed by PCR amplification of the corresponding
regions followed by DNA sequence analysis (not shown).
The first set of ALS3-Renilla reniformis luciferase (RrLUC) promoter fusions
was constructed by PCR amplifying portions of the ALS3 promoter up to posi-
tion 4 of the ALS3 coding region (see Table S1 in the supplemental material)
and cloning these portions between the ClaI and PstI sites in pCRW3 (66). To
create the next sets of RrLUC promoter fusions, new BstEII, NdeI, SpeI, NotI,
and MluI sites were introduced into pCRW3 to make pCRW3N (oligonucleo-
tides KpnSal and SalKpn) (see Table S1 in the supplemental material). A basal
ALS3 promoter region (positions 306 to 4) was then PCR amplified and
inserted between the PstI and MluI sites in pCRW3N, upstream of the RrLUC
open reading frame (ORF). Various promoter ALS3 fragments were cloned as
oligonucleotides or PCR fragments (see Table S1 in the supplemental material)
upstream of this basal ALS3 promoter region. The STRE5-, YRE5-, and GCRE5-
RrLUC fusions were made by cloning oligonucleotides with each sequence
element upstream of a basal RrLUC reporter containing part of the ADH1
promoter region (51, 74) (see Table S1 in the supplemental material). pCRW3-
based plasmids were linearized with HindIII and transformed into C. albicans
CAI8 (Table 1) selecting for the ADE2 marker. Single-copy integration at the
ade2 locus was confirmed by PCR diagnosis.
To test the roles of Bcr1 and Tec1 in C. albicans, a nonrevertible Ura3
segregant of CJN688 (52) was selected (SAC518) (Table 1). SAC518 was trans-
formed with a GFP-HIS1 cassette (19), as described above, to generate the in situ
ALS3-GFP reporter in this bcr1 strain (SAC521). Meanwhile, the TEC1 ORF
was PCR amplified (primers TEC1-F4 and TEC1-R) (see Table S1 in the sup-
plemental material) and cloned into pPYK1-GFP (4). This placed TEC1 under
the control of the PYK1 promoter. pPYK1-TEC1 and the empty control vector
pPYK1 were linearized with StuI and transformed into SAC520 (BCR1) and
SAC521 (bcr1) (Table 1). Single-copy integration at RPS1 was confirmed by PCR
diagnosis (45).
DNA and RNA analysis. DNA was prepared and analyzed by Southern blot-
ting as described previously (25, 78). RNA was isolated and Northern analysis
was performed as described previously (24, 47). The ALS3-specific probe was
PCR amplified using primers ALS3-F and ALS3-R, which were described pre-
viously by Hoyer et al. (28). GFP and ACT1 sequences were analyzed using
probes corresponding to the PCR-amplified ORFs. Primers are specified in
Table S1 in the supplemental material.
Reporter assays. GFP fluorescence in whole C. albicans cells was quantified in
96-well, black, clear-bottomed microplates (Matrix Technologies, Wilmslow,
United Kingdom) using a Tecan Ultra 384 Microplate reader (Tecan Trading
AG, Switzerland) running XFluor 4 software. Fluorescence polarization was
used to distinguish GFP fluorescence from background autofluorescence (34,
35). The method exploits the high fluorescence anisotropy of GFP compared to
other autofluorescing species. The difference between the fluorescence that
polarized parallel to the excitation light and that which polarized perpendicular
to the excitation light was used as the analytical signal. This measurement is
relatively large for GFP and small for autofluorescing molecules. Fluorescence
and fluorescence polarization measurements were made at 485-nm excitation
and 535-nm emission wavelengths, as described previously (35). Means (in “FP
[fluorescence polarization] brightness” units) and standard deviations from two
to eight independent transformants are presented. Observations were reproduc-
ible in at least two independent experiments. Untransformed C. albicans cells
were used as the background control.
Luciferase assays (relative light units/20 g protein/20 s) were performed using
fresh C. albicans protein extracts with a Lumat LB9507 luminometer (EG&G
Berthold) as described previously (46). Means and standard deviations from
quadruplicate assays are presented, and similar data were obtained in three
experiments using independent transformants.
Microscopy. Cell morphology was monitored using an Olympus BX50 micro-
scope and recorded with an Olympus DP11-P digital video camera. Cell numbers
were counted using an Improved Neubauer hemocytometer.
Phase-contrast microscopy and fluorescence microscopy were performed using
an Axioplan 2 microscope (Carl Zeiss, United Kingdom) with filter sets XF66
(blue emission), XF67 (red emission), and XF77 (green emission) from Omega
Optical Inc. (Brattleboro, VT). Images were generated using a Hamamatsu
charge-coupled-device camera and analyzed using Openlab 3.0.9 (Improvision,
Coventry, United Kingdom). C. albicans cells were mounted onto polylysine-
coated glass slides and covered with Vectashield immunofluorescence mounting
medium (Vector Laboratories, Peterborough, United Kingdom) (3).
In silico promoter analysis. Promoter sequences were analyzed for the pres-
ence of putative regulatory elements using MatInspector (12, 56) (http://www
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TABLE 1. C. albicans strains
Strain Genotype or descriptiona Parent strain Reference or source
SC5314 Wild-type clinical isolate 20
CAI4 ura3:: imm434/ura3:: imm434 SC5314 17
CAI8 ura3:: imm434/ura3:: imm434 ade2::hisG/ade2::hisG CAI4 17
RM1000 ura3:: imm434/ura3:: imm434 his1::hisG/his1::hisG CAI4 50
BWP17 ura3:: imm434/ura3:: imm434 arg4::hisG/arg4::hisG his1::hisG/his1::hisG RM1000 79
Ca90 ura3:: imm434/ura3:: imm434 als3::hisG/als3::hisG CAI4 This study
Ca107 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3696-RrLUC CAI8 This study
Ca108 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3496-RrLUC CAI8 This study
Ca109 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3306-RrLUC CAI8 This study
Ca110 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3129-RrLUC CAI8 This study
Ca111 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3100-RrLUC CAI8 This study
Ca176 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3496-307-RrLUC CAI8 This study
Ca167 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3496-461-RrLUC CAI8 This study
Ca619 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3483-445-RrLUC CAI8 This study
Ca168 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3467-421-RrLUC CAI8 This study
Ca620 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3450-405-RrLUC CAI8 This study
Ca169 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3429-417-RrLUC CAI8 This study
Ca170 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3420-386-RrLUC CAI8 This study
Ca621 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3388-352-RrLUC CAI8 This study
Ca171 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3374-307-RrLUC CAI8 This study
Ca622 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3471-321-RrLUC CAI8 This study
Ca623 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3471-338-RrLUC CAI8 This study
Ca624 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3448-321-RrLUC CAI8 This study
Ca625 ura3:: imm434/ura3:: imm434 ade2::hisG/ADE2-ALS3448-338-RrLUC CAI8 This study
SAC500 ura3:: imm434/ura3:: imm434 his1::hisG/his1::hisG ALS3/ALS3-GFP-URA3 RM1000 This study
SAC501 ura3:: imm434/ura3:: imm434 his1::hisG/his1::hisG ALS3/HIS1-ALS31449-GFP-URA3 RM1000 This study
SAC502 ura3:: imm434/ura3:: imm434 his1::hisG/his1::hisG ALS3/HIS1-ALS31449t-GFP-URA3 RM1000 This study
SAC503 ura3:: imm434/ura3:: imm434 his1::hisG/his1::hisG ALS3/HIS1-ALS31438-GFP-URA3 RM1000 This study
SAC504 ura3:: imm434/ura3:: imm434 his1::hisG/his1::hisG ALS3/HIS1-ALS31438t-GFP-URA3 RM1000 This study
SAC505 ura3:: imm434/ura3:: imm434 his1::hisG/his1::hisG ALS3/HIS1-ALS31049-GFP-URA3 RM1000 This study
SAC506 ura3:: imm434/ura3:: imm434 his1::hisG/his1::hisG ALS3/HIS1-ALS31049t-GFP-URA3 RM1000 This study
SAC507 ura3:: imm434/ura3:: imm434 his1::hisG/his1::hisG ALS3/HIS1-ALS3885-GFP-URA3 RM1000 This study
SAC508 ura3:: imm434/ura3:: imm434 his1::hisG/his1::hisG ALS3/HIS1-ALS3885t-GFP-URA3 RM1000 This study
SAC509 ura3:: imm434/ura3:: imm434 his1::hisG/his1::hisG, ALS3/HIS1-ALS3842-GFP-URA3 RM1000 This study
SAC510 ura3:: imm434/ura3:: imm434 his1::hisG/his1::hisG ALS3/HIS1-ALS3842t-GFP-URA3 RM1000 This study
SAC511 ura3:: imm434/ura3:: imm434 his1::hisG/his1::hisG ALS3/HIS1-ALS3696-GFP-URA3 RM1000 This study
SAC512 ura3:: imm434/ura3:: imm434 his1::hisG/his1::hisG ALS3/HIS1-ALS3471-GFP-URA3 RM1000 This study
SAC513 ura3:: imm434/ura3:: imm434 his1::hisG/his1::hisG ALS3/HIS1-ALS3306-GFP-URA3 RM1000 This study
SAC530 ura3:: imm434/ura3:: imm434 ALS3/ALS3-GFP-URA3 CAI4 This study
MMC4 ura3:: imm434/ura3:: imm434 nrg1::hisG/nrg1::hisG CAI4 46
SAC531 ura3:: imm434/ura3:: imm434 nrg1::hisG/nrg1::hisG ALS3/ALS3-GFP-URA3 MMC4 This study
DK158 ura3:: imm434/ura3:: imm434 rfg1::hisG/rfg1::hisG CAI4 31
SAC532 ura3:: imm434/ura3:: imm434 rfg1::hisG/rfg1::hisG ALS3/ALS3-GFP-URA3 DK158 This study
BCa2-10 ura3:: imm434/ura3:: imm434 tup1::hisG/tup1::hisG CAI4 6
SAC533 ura3:: imm434/ura3:: imm434 tup1::hisG/tup1::hisG ALS3/ALS3-GFP-URA3 BCA2-10 This study
SGC124 ura3:: imm434/ura3:: imm434 ade2::hisG/ade2::hisG ssn6::hisG/ssn6::hisG CAI8 18
SAC534 ura3:: imm434/ura3:: imm434 ade2::hisG/ade2::hisG ssn6::hisG/ssn6::hisG ALS3/ALS3-GFP-URA3 SGC124 This study
CHY257 ura3:: imm434/ura3:: imm434 a1 a2::hisG CAI4 43
SAC535 ura3:: imm434/ura3:: imm434 a1 a2::hisG ALS3/ALS3-GFP-URA3 CHY257 This study
JCK18 ura3:: imm434/ura3:: imm434 cph1::hisG/cph1::hisG CAI4 41
SAC536 ura3:: imm434/ura3:: imm434 cph1::hisG/cph1::hisG ALS3/ALS3-GFP-URA3 This study
HLY1927 ura3:: imm434/ura3:: imm434 his1::hisG/his1::hisG cph2::ARG4/cph2::HIS1 CAI4 37
SAC537 ura3:: imm434/ura3:: imm434 his1::hisG/his1::hisG cph2::ARG4/cph2::HIS1 ALS3/ALS3-GFP-URA3 This study
HLC67 ura3:: imm434/ura3:: imm434 efg1::hisG/efg1::hisG CAI4 42
SAC538 ura3:: imm434/ura3:: imm434 efg1::hisG/efg1::hisG ALS3/ALS3-GFP-URA3 HLC67 This study
AS18 ura3:: imm434/ura3:: imm434 tec1::hisG/tec1::hisG (pVEC) CAI4 62
SAC540 ura3:: imm434/ura3:: imm434 tec1::hisG/tec1::hisG (pVEC), post-5-FOA selection AS18 This study
SAC539 ura3:: imm434/ura3:: imm434 tec1::hisG/tec1::hisG (pVEC), post-5-FOA selection, ALS3/ALS3-GFP-URA3 AS18 This study
CJN702 ura3:: imm434/ura3:: imm434 arg4::hisG/arg4::hisG his1::hisG/his1::hisG::pHIS1 bcr1::ARG4/bcr1::URA3 BWP17 52
SAC519 ura3:: imm434/ura3:: imm434 arg4::hisG/arg4::hisG his1::hisG/his1::hisG::pHIS1 bcr1::ARG4/bcr1::URA3,
post-5-FOA selection
CJN702 This study
SAC528 ura3:: imm434/ura3:: imm434 arg4::hisG/arg4::hisG his1::hisG/his1::hisG::pHIS1 bcr1::ARG4/bcr1::URA3,
post-5-FOA selection, ALS3/ALS3-GFP-URA3
CJN702 This study
CJN688 ura3:: imm434/ura3:: imm434 arg4::hisG/arg4::hisG, his1::hisG/his1::hisG bcr1::ARG4/bcr1::URA3 BWP17 52
SAC518 ura3:: imm434/ura3:: imm434 arg4::hisG/arg4::hisG his1::hisG/his1::hisG bcr1::ARG4/bcr1::URA3, post-5-
FOA selection
CJN688 This study
SAC520 ura3:: imm434/ura3:: imm434 arg4::hisG/arg4::hisG his1::hisG/his1::hisG ALS3/ALS3-GFP-HIS1 BWP17 This study
SAC521 ura3:: imm434/ura3:: imm434 arg4::hisG/arg4::hisG his1::hisG/his1::hisG bcr1::ARG4/bcr1::URA3, post-5-
FOA selection, ALS3/ALS3-GFP-HIS1
BWP17 This study
SAC522 ura3:: imm434/ura3:: imm434 arg4::hisG/arg4::hisG his1::hisG/his1::hisG ALS3/ALS3-GFP-HIS1 RPS1-
PYK1-URA3
BWP17 This study
SAC523 ura3:: imm434/ura3:: imm434 arg4::hisG/arg4::hisG his1::hisG/his1::hisG ALS3/ALS3-GFP-HIS1 RPS1-
PYK1-TEC1-URA3
BWP17 This study
SAC524 ura3:: imm434/ura3:: imm434 arg4::hisG/arg4::hisG his1::hisG/his1::hisG bcr1::ARG4/bcr1::ura3 ALS3/
ALS3-GFP-HIS1 RPS1-PYK1-URA3
BWP17 This study
SAC525 ura3:: imm434/ura3:: imm434 arg4::hisG/arg4::hisG his1::hisG/his1::hisG bcr1::ARG4/bcr1::ura3 ALS3/
ALS3-GFP-HIS1 RPS1-PYK1-TEC1-URA3
BWP17 This study
a 5-FOA, 5-fluoroorotic acid.
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.genomatix.de/products/MatInspector/index.html) or Regulatory Sequence Analysis
Tools (76) (http://www. flychip.org.uk/rsa-tools/).
RESULTS
ALS3 transcription is activated specifically during hyphal
development. To confirm that the ALS3 gene is expressed
specifically during hyphal development in C. albicans, we ex-
amined ALS3 mRNA levels by Northern blotting following
exposure to three distinct types of morphogenetic signals: se-
rum (Fig. 1A), neutral pH, and N-acetylglucosamine (not
shown). The ALS3 mRNA was induced in C. albicans cells
growing at 37°C and strongly induced in cells exposed to serum
at 37°C (Fig. 1A). This transcript was undetectable in a C.
albicans als3/als3 null mutant. ALS3 mRNA levels correlated
strongly with the extent of hyphal development in these cul-
tures. The same was true when hyphal development was in-
duced by neutral pH or N-acetylglucosamine (not shown). Our
data confirm data from a previous report by Hoyer et al.
showing that ALS3 is a hypha-specific gene (28).
To test whether the developmental expression pattern of
ALS3 is mediated at a transcriptional or posttranscriptional
level, we generated an ALS3-GFP promoter fusion. This pro-
moter fusion was integrated into the C. albicans genome in situ
at the ALS3 locus (SAC530) (Table 1). The expression of this
reporter was monitored by assaying fluorescence levels in C.
albicans SAC530 cells growing in the presence and absence
of serum (Fig. 1B and C). The ALS3-GFP promoter fusion
displayed an expression pattern that was similar to that of
wild-type ALS3 mRNA, indicating that ALS3 transcription is
induced specifically during hyphal development.
Hypha-specific promoters are unusually long. Having estab-
lished that the developmental regulation of ALS3 is mediated
at the transcriptional level, we performed an in silico compar-
ison of the ALS3 promoter region and other hypha-specific
promoters (ECE1, HGC1, HWP1, HYR1, RBT1, and RBT4).
Our aim was to identify common sequence elements that might
contribute to the coordinate regulation of these genes during
hyphal development. To achieve this, we analyzed the inter-
genic regions that lie upstream of these genes (Fig. 2). Two
main observations were made. First, the 5-intergenic regions
for hypha-specific genes are unusually long compared to C.
albicans genes in general. The estimated average length of
intergenic regions for divergently transcribed C. albicans genes
is 1,088 bp, that for convergently transcribed genes is 521 bp,
and that for tandemly transcribed genes is 770 bp (26). In
contrast, the average length of the upstream intergenic regions
for these seven hypha-specific genes is 4.5 kbp (based on the
latest genome assembly available in the Candida Genome Da-
tabase) (http://www.candidagenome.org/ [accessed October
2006]). The ALS3 intergenic region is 3.0 kbp, and HCG1 has
the longest region at 9.0 kbp. This provided our first clue that
morphogenetically regulated promoters in C. albicans might be
relatively complex. This view is consistent with observations of
budding yeast. For example, the developmentally regulated
FLO11 and HO genes in Saccharomyces cerevisiae both have
unusually long and complex promoters (49, 58).
Our second observation was that hypha-specific promoters
contain putative binding sites for many known transcription
factors in C. albicans. These include putative sites for Efg1,
FIG. 1. ALS3 transcription is activated during hyphal development.
(A) Northern analysis of ALS3 mRNA levels in C. albicans after 3 h of
growth in YPD at 25°C, in YPD containing serum at 25°C, in YPD at
37°C, or in YPD containing serum at 37°C. ALS3, SC5314; als3, Ca90
(Table 1). The proportion of filamentous (as opposed to yeast) cells in
each culture is indicated. (B) Fluorescence microscopy of C. albicans
SAC500 cells containing the in situ ALS3-GFP reporter under equiv-
alent conditions. (C) Quantification of GFP fluorescence in C. albicans
SAC500 cells under the same conditions.
FIG. 2. In silico analysis of hypha-specific promoters. The lengths of the intergenic regions of hypha-specific genes and the organization of
specific sequence elements in their 5 regions are presented. Asterisks, Tec1 sites (CATTCY); open squares, E box (CANNTG); gray circles, Nrg1
sites (MVCCCT); closed triangles, Rfg1 sites (YYYATTGTTCTC). The lengths of the intergenic regions were calculated from assembly 20 of the
C. albicans genome sequence (see the CGD website at www.candidagenome.org/ [accessed September 2006]).
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Tec1, Nrg1, Rfg1, Cph1, Cph2, Rim101, Cap1, and Gcn4.
(Cap1 and Gcn4 are transcription factors that play key roles in
responses to oxidative stress and amino acid starvation, respec-
tively [1, 74].) However, only a small number of these sites are
conserved in all the hypha-specific genes analyzed (Fig. 2).
These include putative Efg1, Tec1, and Nrg1 sites. It should be
noted, however, that the Efg1 consensus site (E box) is likely to
occur by chance in sequences of this length.
Contribution of morphogenetic transcriptional factors to
ALS3 regulation. The ALS3 promoter region contains Nrg1
sites but no obvious Rfg1 sites on the basis of the Rfg1 con-
sensus sequence (Fig. 2). However, genome-wide transcrip-
tional profiling studies have suggested that ALS3 is transcrip-
tionally repressed by Rfg1 as well as by Nrg1 and Tup1 (32, 46).
Therefore, we compared the influence of these transcription
factors upon ALS3 directly by using the in situ ALS3-GFP
reporter (Fig. 3). In S. cerevisiae, Tup1 acts in concert with
Ssn6, forming a Tup1-Ssn6 corepressor complex that represses
the expression of many target genes (64). However, in C. al-
bicans, Ssn6 is not thought to play a role in the Tup1-mediated
repression of hypha-specific genes largely on the basis of tran-
script profiling (18). Therefore, we tested this further by ex-
amining the role of Ssn6 in ALS3 gene regulation. The ALS3
promoter also contains a putative site for the a1/2 repressor,
which involved in the repression of “haploid-specific” genes in
C. albicans (75). Therefore, we included the a1/2 repressor in
this analysis.
The ALS3-GFP-URA3 cassette was transformed into wild-
type, nrg1, rfg1, tup1, ssn6, and mtla1 mtla2 cells. GFP fluores-
cence levels were measured in these C. albicans strains during
growth in the yeast form (Fig. 3B). As expected, the ALS3-
GFP reporter was repressed in wild-type yeast cells. Nrg1 acts
through two NREs in the ALS3 promoter at positions 330
and 80 (46). Hence, the derepression of the ALS3-GFP re-
porter in nrg1 and tup1 cells was also expected (Fig. 3B).
However, this reporter was only partially derepressed in rfg1
cells and was not derepressed in ssn6 or mtla1 mtla2 cells.
These data reinforce the idea that ALS3 is repressed mainly by
Nrg1 and Tup1 in an Ssn6-independent fashion and that Rfg1
plays a minor role in the regulation of ALS3 (18, 32). The data
also suggest that although the ALS3 promoter contains a pu-
tative a1/2 site, this repressor is not required for ALS3 reg-
ulation under these conditions.
The ALS3 promoter also contains putative sites for several
transcription factors that are known to contribute to the acti-
vation of hyphal development: Efg1, Cph1, Cph2, and Tec1.
Therefore, we examined the contributions of these factors to
the activation of ALS3 expression during hyphal development
(Fig. 3). The activity of the in situ ALS3-GFP reporter was
compared in wild-type, efg1, cph1, cph2, and tec1 cells following
serum induction (Fig. 3C). Both Efg1 and Tec1 were required
for the full activation of the ALS3-GFP reporter. In contrast,
Cph2 was not essential for activation, although Cph2 has been
reported to regulate TEC1 (36). We did observe considerable
variation in ALS3-GFP expression levels in the cph2 mutant,
and this is reflected in relatively large error bars even though
this experiment was performed five times with up to eight
independent transformants (Fig. 3C). Decreased ALS3-GFP
expression was observed in cph1 cells, suggesting that this
mitogen-activated protein kinase pathway does contribute to
ALS3 activation following serum stimulation, although this
pathway is not required for hyphal development under these
conditions (10, 42). We also examined the impact of Bcr1 upon
ALS3-GFP; this is discussed below. Taken together, the data
indicate that the transcription factors Efg1, Tec1, Nrg1, and
Tup1 play important roles in regulating ALS3 expression and
that Rfg1 and Cph1 contribute to ALS3 regulation.
The ALS3 promoter contains two main activation regions. A
set of mutations was generated at the ALS3 locus to examine
the organization of its promoter. These mutations were gen-
erated by inserting a HIS1 cassette at a range of positions in
the 5 intergenic region of the ALS3-GFP allele in C. albicans
strain SAC500 (Table 1). Essentially, this created a set of
promoter mutations in situ at the ALS3 locus, the activities of
which were monitored during hyphal development by measur-
ing GFP fluorescence following serum stimulation.
The removal of sequences between positions 1438 and
1049 (with respect to the first base of the coding region) from
the promoter caused a twofold decrease in the activity of the
ALS3-GFP allele (Fig. 4). The further removal of sequences
between positions 1049 and 471 had no significant effect
upon expression. However, the removal of sequences between
positions 471 and 306 blocked ALS3-GFP activation com-
pletely. We conclude that the full activation of ALS3 depends
upon two promoter regions. One region (A1 [positions 471
to 306]) is essential for activation, while a second region (A2
[positions 1438 to 1049]) enhances this activation.
FIG. 3. Contribution of transcriptional regulators to the regulation
of ALS3. (A) Cartoon illustrating the putative impact of transcriptional
activators and repressors upon hyphal development. MAP, mitogen-
activated protein; cAMP, cyclic AMP. (B) Effect of repressor muta-
tions upon the expression of the ALS3-GFP reporter after growth for
2 h in YPD at 25°C. (C) Effect of inactivating transcriptional activators
on the ALS3-GFP reporter after 90 min of growth in YPD containing
serum at 37°C. wt, wild type.
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We examined the kinetics of induction of ALS3-GFP tran-
scripts to further investigate the contributions of the A1 and
A2 activation regions to the hypha-specific induction of
ALS3. Northern analysis was performed on C. albicans
SAC501, SAC505, and SAC513 cells following serum stim-
ulation. SAC501 contains both the A1 and A2 activation
regions (ALS31499-GFP), and SAC505 lacks A2 but contains
A1 (ALS31049-GFP), whereas SAC513 lacks both A1 and A2
(ALS3306-GFP). All three strains developed hyphae at similar
rates following serum stimulation, as expected. However, no
induction of GFP mRNA was observed for the negative control
containing the ALS3306-GFP fusion (Fig. 5). In contrast, GFP
mRNA was strongly induced from the positive control contain-
ing both activation regions, reaching a maximum at 60 min.
Similar kinetics of GFP mRNA induction were observed for
the ALS3-GFP construct that contains only the A1 region.
However, the GFP mRNA levels reached only about one-third
of those in the positive control (Fig. 5), which correlates well
with GFP fluorescence levels from these and related constructs
(Fig. 4). This reproducible observation was consistent with the
idea that the A1 region is essential for transcriptional activa-
tion during hyphal development, while the A2 region increases
the amplitude of this activation.
The ALS3 promoter is complex. To examine the essential
activation region (A1) in more detail, we turned to the sensi-
tive RrLUC reporter (66). First, we tested the robustness of
this approach for the dissection of the ALS3 promoter. A set of
ALS3-RrLUC promoter fusions containing or lacking the A1
region were integrated into the genome of C. albicans CAI8,
and their expression was examined in yeast and hyphal cells. As
expected, all of these constructs were inactive in yeast cells (not
shown), and only those containing the A1 region (positions
496 to 306) were induced in hyphal cells (Fig. 6A). This
indicated that the ALS3-RrLUC fusions accurately reflected
the behavior of in situ ALS3-GFP fusions and confirmed the
presence of an essential activation region in this part of the
promoter.
Additional ALS3-RrLUC constructs were generated to fur-
ther define the 5 and 3 ends of the A1 region. Hypha-specific
activation was lost if 5 sequences between positions 471 and
448 were deleted (not shown). Activation was retained if 3
FIG. 4. Effect of in situ promoter mutations upon ALS3-GFP expression. GFP fluorescence was quantified in each C. albicans SAC strain
(Table 1) after 90 min of growth in YPD containing serum at 37°C. The coordinate of each promoter deletion endpoint is provided. Wild-type Tec1
sites are indicated by black boxes, and mutated Tec1 sites are indicated by gray boxes.
FIG. 5. Kinetic analysis of ALS3-GFP transcript levels during se-
rum-induced hyphal development. (A) Northern analysis of ALS3-
GFP transcripts at various times (minutes) after the serum induction of
C. albicans strains carrying different promoter deletions (Table 1). A1
A2, SAC501 cells in which the ALS3-GFP fusion contains both acti-
vation regions; A1 A2, SAC505 cells in which the ALS3-GFP fusion
contains only the A1 activation region; A1 A2, SAC513 cells in
which the ALS3-GFP fusion lacks both activation regions. PCR-am-
plified ALS3 and ACT1 probes were used (see Materials and Meth-
ods). (B) Quantification of ALS3-GFP transcript levels relative to the
internal ACT1 mRNA control. Similar results were obtained when
quantifying relative to 26S rRNA. Also, similar results were obtained
in a second independent experiment.
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sequences between positions 321 and 307 were removed,
but further 3 deletions to position 331 resulted in reduced
levels of expression in hyphal cells and the derepression of
RrLUC expression in yeast cells. This was consistent with the
disruption of activating sequences and the loss of Nrg1-medi-
ated repression through the deletion of the NRE at position
330. We concluded that the A1 activation region lies between
positions 471 and 321. This activation region does not
correlate well with an in silico analysis of putative regulatory
elements in the ALS3 promoter (Fig. 2), reinforcing the view
that in isolation, in silico analyses of promoter elements are a
poor predictor of regulatory function.
In an attempt to define the A1 region more precisely, we
generated a further set of RrLUC constructs containing short
overlapping fragments from the A1 region. None of these
constructs displayed expression levels equivalent to those of
FIG. 6. Analysis of the A1 activation region in the ALS3 promoter. Various RrLUC promoter-RrLUC fusions were constructed and trans-
formed into C. albicans CAI8 (Table 1). The expression levels of these luciferase fusions were assayed after 3 h of growth in YPD containing serum
at 37°C. (A) The expression of ALS3 promoter deletions that target the A1 activation region was assayed. (B) Fragments of the A1 activation
region were cloned upstream of the ALS3306-RrLUC fusion, and the expression of these constructs was assayed. Black boxes, putative YRE; gray
boxes, putative GCRE. (C) Oligonucleotides containing multiple STREs, YREs, or GCREs were cloned upstream of a basal RrLUC reporter, and
the luciferase levels generated by these constructs were assayed.
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the control (Fig. 6B), indicating that no single enhancer ele-
ment within the A1 region was sufficient to confer hypha-
specific activation. Weak activation (	20% of the control) was
observed for some fragments. This might have suggested that
multiple copies of a weak element could combine to provide
strong activation. However, none of these fragments shared
any obvious sequence elements.
Putative binding sites for the transcription factors Msn4/
Msn2 (STRE [C4T]), Cap1 (YRE [TTA[G/C]TAA]), and
Gcn4 (GCRE [TGACTC]) do exist in the promoters of hypha-
specific genes, and these elements are present in ALS3 pro-
moter fragments that provide weak transcriptional activation.
Therefore, we tested whether STRE, YRE, or GCRE ele-
ments can activate transcription in response to serum induc-
tion (Fig. 6C). The YRE- and GCRE-RrLUC reporters dis-
played weak activation compared with the ALS3-RrLUC
control, suggesting that these elements might contribute to the
weak activation seen for the short ALS3 promoter fusions
examined in Fig. 6B. However, the YRE element mediates
transcriptional activation in C. albicans yeast cells in response
to oxidative stress (51), and the GCRE activates transcription
in yeast cells in response to amino acid starvation (74). Neither
Cap1 nor Gcn4 is required for serum-induced morphogenesis.
Hence, these elements cannot account for the hypha specificity
of the A1 promoter region. Nevertheless, it is conceivable that
YRE and GCRE elements might contribute to the transcrip-
tional activation of hypha-specific genes in the context of the
natural promoters.
Taken together, the data suggest that the A1 promoter re-
gion is complex. Sequence elements close to the 5 and 3 ends
of this region are required for the transcriptional activation of
ALS3 during hyphal development. These elements appear to
function in combination to mediate hypha-specific activation.
Tec1 acts indirectly through Bcr1 to regulate ALS3 tran-
scription. Putative Tec1 sites exist in all hypha-specific pro-
moter regions (Fig. 2). Five such sites are present in the ALS3
promoter at positions 1499, 1438, 1049, 885, and 842.
Furthermore, Tec1 is required for the morphogenetic activa-
tion of ALS3 (Fig. 3C). Therefore, we reasoned that Tec1
might act directly upon the ALS3 promoter via (some of) the
putative Tec1 sites. To test this, we generated a set of in situ
ALS3 promoter mutants in which the Tec1 sites were sequen-
tially inactivated and compared them to a parallel set of con-
trol mutations containing the Tec1 sites (Fig. 4 and Table 1).
No significant difference in expression level was observed be-
tween each Tec1 site mutation (Fig. 4, gray bars) and its cor-
responding control (black bars). This indicated that the puta-
tive Tec1 sites are not required for the hypha-specific
activation of ALS3 and hence that Tec1 might act indirectly
upon this gene.
Recently, Nobile and Mitchell (52) identified BCR1 as being
a regulator of biofilm formation in C. albicans. During the
course of that work, they showed that ALS3 mRNA levels are
reduced in bcr1 cells and that BCR1 expression is reduced in a
tec1 mutant. This raised the possibility that Tec1 might regu-
late ALS3 indirectly via Bcr1. We tested this idea by first asking
whether BCR1 is required for the transcriptional activation of
the ALS3-GFP reporter. ALS3-GFP expression was lost in bcr1
cells, indicating that Bcr1 is essential for the transcriptional
activation of ALS3 during hyphal development (Fig. 3C). We
then tested whether TEC1 overexpression enhances ALS3 ex-
pression and whether this effect is dependent upon BCR1.
TEC1 overexpression was engineered by transforming a PYK1-
TEC1 fusion into C. albicans SAC520 cells and growing them
on glucose-containing medium to activate the PYK1 promoter
(4). This led to the significant overexpression of ALS3-GFP
(Fig. 7). This overexpression was blocked in a bcr1 mutant
background, confirming that Tec1 acts indirectly upon ALS3
transcription via Bcr1.
DISCUSSION
Yeast-hypha morphogenesis has been studied intensively in
C. albicans because of its likely contribution to the pathoge-
nicity of this fungus (21, 22, 29, 61, 71, 83). A complex network
of signaling pathways has been shown to control hyphal devel-
opment, but the mechanistic relationships between these path-
ways remain obscure (10). These signaling pathways are
thought to converge on the promoters of those genes that
respond specifically during hyphal development (7, 10). ALS3
is one of a small set of hypha-specific genes in C. albicans that
includes ALS3, ECE1, HGC1, HWP1, HYR1, RBT1, and RBT4
(2, 5, 8, 28, 40, 48, 67, 83). In this study, we have confirmed that
the hypha-specific activation of ALS3 is mediated at the tran-
scriptional level (Fig. 1). Clearly, a complete understanding of
morphogenetic signaling depends upon the dissection of hy-
pha-specific promoters and the mechanisms by which these
pathways regulate these promoters.
We have shown that ALS3 is regulated by a complex array of
transcription factors: Efg1, Cph1, Tec1, Bcr1, Nrg1, Rfg1, and
Tup1 (Fig. 3). When C. albicans cells grow in the yeast form,
ALS3 transcription is repressed mainly by Nrg1, which binds to
NREs located at positions 330 and 80 in the promoter (46).
Rfg1 also contributes to ALS3 repression (Fig. 3) (32), but the
promoter element(s) through which Rfg1 operates in C. albi-
cans has not been experimentally defined. Both Nrg1 and Rfg1
are thought to act by interacting with the global repressor
Tup1, which mediates transcription through direct interactions
FIG. 7. Effect of ectopic TEC1 expression and BCR1 inactivation
on ALS3-GFP expression. The in situ ALS3-GFP reporter was intro-
duced into wild-type (BCR1) and bcr1 cells, and these strains were
transformed with the empty PYK1 expression vector (v) or the PYK1-
TEC1 plasmid (TEC1) to generate strains SAC522 (v) (BCR1),
SAC523 (TEC1) (BCR1), SAC524 (v) (bcr1), and SAC525 (TEC1)
(bcr1) (Table 1). GFP fluorescence levels were assayed in these strains
after 90 min of growth in YPD-containing serum at 37°C.
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with the transcription complex, by positioning nucleosomes on
the promoter, or by a combination of both mechanisms (23,
80). In S. cerevisiae, interactions between Tup1 and its cognate
DNA binding proteins often depend on Ssn6 (64). However,
this does not appear to be the case for Nrg1 in the context of
hypha-specific genes. It has been suggested that the repression
of hypha-specific genes by Nrg1 and Tup1 does not depend
upon Ssn6 (18), and we have confirmed this for ALS3 in this
study (Fig. 3).
Cph1 and the A2 region of the promoter are required only
for full ALS3 activation. This might suggest that Cph1 en-
hances ALS3 transcription via the A2 region. However, there
are no obvious occurrences of the putative Cph1 consensus site
in the ALS3 promoter, and therefore, Cph1 might act indi-
rectly to regulate ALS3 transcription (Fig. 8).
In contrast, Efg1 is essential for the transcriptional activa-
tion of ALS3 during hyphal development (Fig. 3C). Efg1 has
been shown to bind an E box in vitro (40), and hypha-specific
promoters do contain this type of sequence element (Fig. 2).
However, the degenerate E-box consensus is likely to occur
frequently by chance (1/256), and to date, there are no reports
confirming that Efg1 regulates transcription via the E box in C.
albicans.
Although Tec1 is essential for the activation of ALS3 (Fig. 4)
and putative Tec1 sites exist in the ALS3 promoter (Fig. 2),
these sites do not contribute significantly to ALS3 activation
(Fig. 4). Instead, Tec1 regulates ALS3 transcription indirectly
through Bcr1 (Fig. 7), which is also essential for ALS3 activa-
tion (Fig. 3). These observations are entirely consistent with
recent data from Nobile et al. They showed that Tec1 and Bcr1
are required for the formation of biofilms in C. albicans and
that Bcr1 acts downstream of Tec1 to regulate the expression
of adhesin genes required for biofilm formation, such as ALS3
and HWP1 (52, 53).
The transcriptional activation of ALS3 is dependent upon
the A1 promoter region (Fig. 4) as well as upon Efg1, Tec1,
and Bcr1 (Fig. 3). The A1 promoter region is complex: no
single sequence element within this 150-bp region was capable
of driving hypha-specific expression, and the trimming of se-
quences at either the 5 or 3 end of this A1 region blocked
hypha-specific activation (Fig. 6). This is consistent with the
idea that several different regulatory factors converge upon the
A1 region to cooperate in ALS3 activation. Hence, Tec1-Bcr1
and Efg1 might regulate ALS3 cooperatively via the A1 pro-
moter region (Fig. 8). An NRE lies at the 3 border of the A1
region at position 330. It has been reported that Nrg1 might
act as a transcriptional activator under some circumstances
(47, 59). Hence, it is conceivable that Nrg1 might also contrib-
ute to the hyphal activation of ALS3.
In parallel studies, Kim and coworkers (33) made similar
observations about the regulation of a second hypha-specific
gene, HWP1. The HWP1 promoter also contains two activation
regions. One region, which binds an array of chromatin remod-
eling proteins, is essential for HWP1 activation, whereas the
second distal region increases the amplitude of this activation
(33). Hence, this class of developmentally regulated genes ap-
pears to be controlled by complex interactions between several
critical transcription factors at the level of their promoters. It
has long been recognized that C. albicans responds to an ex-
tremely disparate range of environmental conditions by form-
ing hyphae (54). The unusual length of promoters of hypha-
specific genes and the complexity and diversity of factors
regulating their transcription not only are compatible with the
diversity of conditions known to favor hypha formation but
also suggest that morphogenetic changes in C. albicans may be
affected by events in several regulatory pathways whose stim-
ulation may not always be specifically or directly related to cell
shape.
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